Tolterodine, a New Antimuscarinic Agent: As Effective but Better Tolerated Than Oxybutynin in Patients With an Overactive Bladder

No AccessJournal of UrologyUrological Survey: Abstracts: Voiding Function and Dysfunction, and Female Urology1 Mar 1999Tolterodine, a New Antimuscarinic Agent: As Effective but Better Tolerated Than Oxybutynin in Patients With an Overactive Bladder P. Abrams, R. Freeman, C. Anderstrom, and A. Mattiasson P. AbramsP. Abrams More articles by this author , R. FreemanR. Freeman More articles by this author , C. AnderstromC. Anderstrom More articles by this author , and A. MattiassonA. Mattiasson More articles by this author View All Author Informationhttps://doi.org/10.1016/S0022-5347(01)61867-6AboutFull TextPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookLinked InTwitterEmail "Tolterodine, a New Antimuscarinic Agent: As Effective but Better Tolerated Than Oxybutynin in Patients With an Overactive Bladder." The Journal of Urology, 161(3), pp. 1038–1039 Bristol Urological Institute, Southmead Hospital, Bristol and Urogynaecology Unit, Derriford Hospital, Plymouth, United Kingdom, and Urologkliniken, Karnsjukhuset, Skovde and Lund, Sweden© 1999 by American Urological Association, Inc.FiguresReferencesRelatedDetails Volume 161Issue 3March 1999Page: 1038-1039 Advertisement Copyright & Permissions© 1999 by American Urological Association, Inc.MetricsAuthor Information P. Abrams More articles by this author R. Freeman More articles by this author C. Anderstrom More articles by this author A. Mattiasson More articles by this author Expand All Advertisement PDF downloadLoading ...